Form D · Biotechnology
NRX Pharmaceuticals, Inc.
Wilmington, DE · CIK 0001719406
Offering snapshot reported Mar 7, 2025 · SEC filing
- Reported sold
- $3.5M Offering amount: $3.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 27, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 7, 2025 | Initial | $3,500,000 | No comparison | 2 | SEC filing |
| Nov 22, 2017 | Initial | $2,525,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $245K
- Finders' fees
- $0
- Form D file number
- 021-540196
In association with a registered offering of shares of the Company's common stock, the Company offered and sold, in a private placement, warrants to purchase shares of common stock.
The Issuer paid D. Boral Capital, LLC, a tail fee of $245,000 in association with the offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| D. Boral Capital | 103792 |
Source: Form D, filed Mar 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Abrams | Executive |
| Richard Ackerman | Director, Executive |
| Richard Bardoff | Director |
| Kim Bennett | Executive |
| Patrick Flynn | Director |
| Michael Fong | Director |
| Chaim Hurvitz | Director |
| Jonathan Javitt | Director, Executive |
| Stuart F. Koenig | Director |
| Dennis Mc Bride | Director |
| Albert G. Rex | Director |
| Michael Taylor | Director |
| Troy T. Taylor | Director |
| Lori B. Wittman | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1201 Orange Street Suite 600
Wilmington, DE, 19801
Wilmington, DE, 19801